Latest news
Zai Lab Announces Second Quarter 2026 Financial Results and Recent Corporate Updates - BioSpaceBioSpace · Thu, 06 Aug 2026 12:39:13 GMTFDA Names Zocilurtatug Pelitecan Orphan Drug in Neuroendocrine Carcinomas - Targeted OncologyTargeted Oncology · Wed, 05 Aug 2026 16:09:36 GMTFDA grants orphan drug designation to Zai Lab's zoci for neuroendocrine carcinomas - AllSciAllSci · Tue, 04 Aug 2026 12:20:33 GMTFDA Grants Orphan Drug Designation to Zocilurtatug Pelitecan for Neuroendocrine Carcinomas - OncLiveOncLive · Mon, 03 Aug 2026 15:59:22 GMTZai Lab says FDA grants Orphan Drug Designation for zocilurtatug pelitecan - TipRanksTipRanks · Mon, 03 Aug 2026 12:21:26 GMTU.S. FDA Grants Orphan Drug Designation to Zai Lab’s DLL3-Targeting ADC Zocilurtatug Pelitecan (Zoci) for the Treatment of Neuroendocrine Carcinomas (NECs) - Business WireBusiness Wire · Mon, 03 Aug 2026 11:00:00 GMT